A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection

NCT00807794 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Diseases

Interventions

DRUG: MEDI-507
DRUG: MEDI-507
DRUG: MEDI-507
DRUG: MEDI-507
DRUG: MEDI-507

Sponsor

MedImmune LLC